UK small-cap RNS · 28 May 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

Sort: Newest · Largest companies

08:00

Sanderson Design Group SDG £53m
Annual Report and Notice of AGM Results
Only publishes the annual report and AGM notice for the year to 31 January 2026; the results themselves were announced on 29 April, so this adds no new financial information.

−1.4% on the day
07:07

Microsalt SALT £20m
Final Results Results
Final Results for the year ended 31 December 2025

first in 8 months −15.6% on the day
07:05

IQE IQE £471m
FY 2025 Financial Results Results
FY 2025 revenue of £97.3m and adjusted EBITDA of £3.2m met the guided ranges (top of EBITDA range), but revenue fell 17.6% and EBITDA 60% as wireless slumped and assets sat underused.

£81.0m · 17% of mcapin lineoutlook positivefirst in 8 months −6.0% on the day

Moved: HSBC covenant and liquidity: Repayment depends on Fundraising completing → Repayment planned from fundraise proceeds · MACOM investment and fundraising: Placing and Retail Offer closed; awaiting vote and approvals → Fundraise announced; completion pending
07:00

Flowtech Fluidpower FLO £52m
2025 Annual Report Posting & Notice of AGM Results
The Company confirms that the 2025 Annual Report and Financial Statements for the year ended 31 December 2025 (Report), together with the Notice convening the 2026 Annual General Meeting (AGM), and Form of Proxy have been sent to all shareholders yesterday by …

+8.5% on the day
07:00

DP Poland DPP £58m
Final Results Results
DP Poland, the operator of pizza stores and restaurants across Poland and Croatia, announces its audited results for the year ended 31 December 2025.

first in 8 months +0.0% on the day
07:00

Nuformix NFX £2.6m
Half-year Results Results
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces its unaudited results for the six months ended 31 March 2026.

5% of mcap −2.9% on the day
07:00

Alkemy Capital Investments ALK £26m
Annual Report & Financial Statements Results
Alkemy Capital Investments plc ("Alkemy") (ALK:LSE) (JV2:FRA) is pleased to announce the publication of its audited Annual Report and Accounts for the year ended 31 January 2026 (the "Annual Report").

first in 7 months −12.4% on the day